Angiex
PrivateLast Round
VC Round
Nov 17, 2025
Total Funding Raised
$48.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Angiex is a biopharmaceutical company that develops vascular-targeted biotherapeutics and nuclear-delivered antibody-drug conjugates for the treatment of solid cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Angiex Comparables
Compare Angiex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adcendo | 87% | |
| Adcytherix | 81% | |
| Adcentrx Therapeutics | 81% | |
Angiex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 17, 2025 | ||||
| Series B | Aug 18, 2021 | ||||
| Seed | Jul 27, 2017 | ||||
| Grant | Nov 2, 2016 |
Key People
Founding team and executive leadership
Angiex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paulson Investment Company | VC Round |
| Presight Capital | Series B |
| Starling Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Presented in vivo data for AGX101, a cancer therapy candidate.
- Apr 17, 2026
Presenting preclinical data for AGX101 at the AACR Annual Meeting.
Angiex Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Angiex's valuation, stock price, and market status.